Antagen Biosciences Inc
Dba Antagen
CAGE Code: 59GJ1
NCAGE Code: 59GJ1
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 828948658
Summary
Antagen Biosciences Inc, Dba Antagen is an Active Commercial Supplier with the Cage Code 59GJ1 and is tracked by Dun & Bradstreet under DUNS Number 828948658..
Address
780 Dedham St Ste 800
Canton MA 02021-1417
United States
Points of Contact
- Telephone:
- 6173473705
-
http://www.antagenpharm.com/
Related Information
People who viewed this 'CAGE Code' also viewed...
Dlh Industries, Inc. Flexible Technologies Co B And D Industrial Parts Inc Codex Corp Sub Of Motorola Inc Watkins Machine And Tool Inc Hammond Construction Inc Evans Industries Inc New England Asbestos Removal Inc Draper Knitting Company, Inc. Hall Wood Products Inc Saint Lawrence University Office Of Schleder Marla Dawkins General Contractors Inc Chevillon-Quick Oil Co Bts Inc Communication Resources, Inc Esmet Inc Sub Of Unimet Corp Robertshaw Controls Co Robertshaw Controls Co Kone Inc.
Frequently Asked Questions (FAQ) for CAGE 59GJ1
- What is CAGE Code 59GJ1?
- 59GJ1 is the unique identifier used by NATO Organizations to reference the physical entity known as Antagen Biosciences Inc Dba Antagen located at 780 Dedham St Ste 800, Canton MA 02021-1417, United States.
- Who is CAGE Code 59GJ1?
- 59GJ1 refers to Antagen Biosciences Inc Dba Antagen located at 780 Dedham St Ste 800, Canton MA 02021-1417, United States.
- Where is CAGE Code 59GJ1 Located?
- CAGE Code 59GJ1 is located in Canton, MA, USA.
Contracting History for CAGE 59GJ1 Most Recent 25 Records
- 75N93022C00020
- Antagen
- 30 Aug 2023
- Antagen
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00020
- Award To Antagen Pharmaceuticals
- 5 Jul 2022
- Award To Antagen Pharmaceuticals
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00020
- Award To Antagen Pharmaceuticals
- 25 Aug 2023
- Award To Antagen Pharmaceuticals
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00020
- Award To Antagen Pharmaceuticals
- 5 Jul 2022
- Award To Antagen Pharmaceuticals
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $300,000.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00011
- The Goal Of The Proposed Project Is To Further Develop Antagen's Novel Protein Nanoparticle-Based Expression And Delivery System Using Fcrider Technology And Antibody Afucosylation Technology To Produce A2,6-Sialylated Afucosylated Env-Fcrider (
- 24 Jun 2022
- The Goal Of The Proposed Project Is To Further Develop Antagen's Novel Protein Nanoparticle-Based Expression And Delivery System Using Fcrider Technology And Antibody Afucosylation Technology To Produce A2,6-Sialylated Afucosylated Env-Fcrider (
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $299,998.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00011
- Fcrider-Based Expression And Delivery Of Stable Env Immunogens For Hiv Vaccines
- 24 May 2023
- Fcrider-Based Expression And Delivery Of Stable Env Immunogens For Hiv Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $299,998.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00042
- Sbir Topic 081: Adjuvant Development For Vaccines Against Infectious Or Immune-Mediated Diseases
- 20 Aug 2020
- Sbir Topic 081: Adjuvant Development For Vaccines Against Infectious Or Immune-Mediated Diseases
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $600,000.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00042
- Eo14042 Sbir Topic 081: Adjuvant Development For Vaccines Against Infectious Or Immune-Mediated Diseases
- 13 Oct 2021
- Eo14042 Sbir Topic 081: Adjuvant Development For Vaccines Against Infectious Or Immune-Mediated Diseases
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $600,000.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00042
- Small Business Innovation Research (Sbir) - (Phs 2020-1)
- 1 Nov 2023
- Small Business Innovation Research (Sbir) - (Phs 2020-1)
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $600,000.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00017
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturi
- 30 Jun 2020
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturi
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,997.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00017
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturi
- 4 Dec 2019
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturi
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,997.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00014
- Eo14042-The Objective Of This Contract Is To Use Immunogens (Envs) Combined With Effective Multivalent Antigenic Display On Nanoparticles (Nps) For Delivery To Promote Strong And Long-Lived Neutralizing Antibody Responses Against Hiv And Direct Affin
- 1 Dec 2021
- Eo14042-The Objective Of This Contract Is To Use Immunogens (Envs) Combined With Effective Multivalent Antigenic Display On Nanoparticles (Nps) For Delivery To Promote Strong And Long-Lived Neutralizing Antibody Responses Against Hiv And Direct Affin
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,914.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00017
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturing Setting.
- 26 Jul 2018
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturing Setting.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,997.00
- Department Of Health And Human Services (Hhs)
- 75N93018C00017
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturi
- 28 Dec 2020
- The Purpose Of This Contract Is To Evaluate And Modulate The Molecular Pathways Involved In Regulating And Enhancing Hiv Envelope/Antigen Expression In Mammalian Cell Lines And To Accelerate Development Of Purification Platforms In A Cgmp Manufacturi
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,997.00
- Department Of Health And Human Services (Hhs)
- HHSD200201564147C
- 6M19
- 22 Apr 2022
- 6M19
- Cdc Office Of Acquisition Services
- Department Of Health And Human Services (Hhs)
- $1,000,000.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00014
- The Objective Of This Contract Is To Use Immunogens (Envs) Combined With Effective Multivalent Antigenic Display On Nanoparticles (Nps) For Delivery To Promote Strong And Long-Lived Neutralizing Antibody Responses Against Hiv And Direct Affinity Matu
- 10 Jun 2021
- The Objective Of This Contract Is To Use Immunogens (Envs) Combined With Effective Multivalent Antigenic Display On Nanoparticles (Nps) For Delivery To Promote Strong And Long-Lived Neutralizing Antibody Responses Against Hiv And Direct Affinity Matu
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $599,914.00
- Department Of Health And Human Services (Hhs)